AU2001266124A1 - 2-aminothiazoline derivatives and their use as no-synthase inhibitors - Google Patents
2-aminothiazoline derivatives and their use as no-synthase inhibitorsInfo
- Publication number
- AU2001266124A1 AU2001266124A1 AU2001266124A AU6612401A AU2001266124A1 AU 2001266124 A1 AU2001266124 A1 AU 2001266124A1 AU 2001266124 A AU2001266124 A AU 2001266124A AU 6612401 A AU6612401 A AU 6612401A AU 2001266124 A1 AU2001266124 A1 AU 2001266124A1
- Authority
- AU
- Australia
- Prior art keywords
- synthase inhibitors
- aminothiazoline
- derivatives
- aminothiazoline derivatives
- synthase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/18—Nitrogen atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0007397A FR2810037B1 (fr) | 2000-06-09 | 2000-06-09 | Utilisation de derives de 2-aminothiazoline comme inhibiteurs de no-synthase inductible |
FR0007397 | 2000-06-09 | ||
PCT/FR2001/001760 WO2001094325A1 (fr) | 2000-06-09 | 2001-06-07 | Derives de 2-aminothiazoline et leur utilisation comme inhibiteurs de no-synthase |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001266124A1 true AU2001266124A1 (en) | 2001-12-17 |
Family
ID=8851134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001266124A Abandoned AU2001266124A1 (en) | 2000-06-09 | 2001-06-07 | 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1299365B1 (fr) |
JP (1) | JP4238026B2 (fr) |
KR (1) | KR20030025931A (fr) |
CN (1) | CN1202096C (fr) |
AP (1) | AP2002002708A0 (fr) |
AR (1) | AR029937A1 (fr) |
AT (1) | ATE305460T1 (fr) |
AU (1) | AU2001266124A1 (fr) |
BR (1) | BR0111986A (fr) |
CA (1) | CA2411760C (fr) |
DE (1) | DE60113689T2 (fr) |
DK (1) | DK1299365T3 (fr) |
DZ (1) | DZ3367A1 (fr) |
EA (1) | EA200300010A1 (fr) |
EC (1) | ECSP024375A (fr) |
ES (1) | ES2248347T3 (fr) |
FR (1) | FR2810037B1 (fr) |
HK (1) | HK1057900A1 (fr) |
HR (1) | HRP20020970A2 (fr) |
HU (1) | HUP0301000A2 (fr) |
IL (1) | IL153328A0 (fr) |
MA (1) | MA25814A1 (fr) |
MX (1) | MXPA02012071A (fr) |
NO (1) | NO20025884L (fr) |
NZ (1) | NZ522968A (fr) |
OA (1) | OA12286A (fr) |
PL (1) | PL360285A1 (fr) |
WO (1) | WO2001094325A1 (fr) |
ZA (1) | ZA200209769B (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60140964D1 (en) * | 2001-09-26 | 2010-02-11 | Yissum Res Dev Co | Sphingolipiden |
CA2465691C (fr) * | 2001-11-09 | 2011-07-19 | Aventis Pharma S.A. | Derives de 2-amino-4-heteroarylethyl thiazoline et leur utilisation comme inhibiteurs de no-synthase inductible |
DE60234117D1 (de) * | 2001-11-09 | 2009-12-03 | Aventis Pharma Sa | 2-amino-4-pyridylmethyl-thiazolinderivate und ihre verwendung als induzierbare no-synthase inhibitoren |
PL370324A1 (en) * | 2001-11-09 | 2005-05-16 | Aventis Pharma S.A. | 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
AU2002238889A1 (en) * | 2002-03-14 | 2003-09-22 | Dainippon Pharmaceutical Co., Ltd. | Nitrogen monoxide synthase inhibitors |
CA2494323C (fr) * | 2002-08-07 | 2011-01-25 | Neuraxon Inc. | Composes d'amino benzothiazole a activite inhibitrice de nos |
DE10332560B4 (de) * | 2003-07-11 | 2010-07-08 | Chiracon Gmbh | Verfahren zur Herstellung von ß- Heteroaryl-2-alanin-Verbindungen über 2-Amino-2-(heteroarylmethyl)-carbonsäure-Verbindungen |
KR101800507B1 (ko) | 2015-09-18 | 2018-01-18 | 주식회사 이엔이티아이 | 자동세척 스크린과 식물정화장치를 활용하여 지속적으로 유입되는 생활하수나 공정폐수가 유입되는 오염하천정화를 위한 방법 및 그 장치 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5066662A (en) * | 1990-05-21 | 1991-11-19 | Warner-Lambert Company | Substituted oxazolidin-2-ones and 1,2,4-oxadiazolin-5-ones and derivatives thereof acting at muscarinic receptors |
SI9300616A (en) * | 1992-11-27 | 1994-06-30 | Wellcome Found | Enzyme inhibitors |
CA2173468A1 (fr) * | 1993-10-21 | 1995-04-27 | Donald W. Hansen, Jr. | Derives amidino utiles en tant qu'inhibiteurs de la synthase de l'oxyde nitrique |
AU4149696A (en) * | 1994-11-15 | 1996-06-06 | Merck & Co., Inc. | Substituted heterocycles as inhibitors of nitric oxide synthase |
AU2223501A (en) * | 1999-12-24 | 2001-07-09 | Kyowa Hakko Kogyo Co. Ltd. | Fused purine derivatives |
-
2000
- 2000-06-09 FR FR0007397A patent/FR2810037B1/fr not_active Expired - Fee Related
-
2001
- 2001-06-07 AR ARP010102730A patent/AR029937A1/es not_active Application Discontinuation
- 2001-06-07 MX MXPA02012071A patent/MXPA02012071A/es active IP Right Grant
- 2001-06-07 EP EP01943580A patent/EP1299365B1/fr not_active Expired - Lifetime
- 2001-06-07 DE DE60113689T patent/DE60113689T2/de not_active Expired - Lifetime
- 2001-06-07 NZ NZ522968A patent/NZ522968A/en unknown
- 2001-06-07 DZ DZ013367A patent/DZ3367A1/fr active
- 2001-06-07 BR BR0111986-9A patent/BR0111986A/pt not_active Application Discontinuation
- 2001-06-07 HU HU0301000A patent/HUP0301000A2/hu unknown
- 2001-06-07 PL PL36028501A patent/PL360285A1/xx unknown
- 2001-06-07 CN CNB01813386XA patent/CN1202096C/zh not_active Expired - Fee Related
- 2001-06-07 DK DK01943580T patent/DK1299365T3/da active
- 2001-06-07 IL IL15332801A patent/IL153328A0/xx unknown
- 2001-06-07 AP APAP/P/2002/002708A patent/AP2002002708A0/en unknown
- 2001-06-07 CA CA002411760A patent/CA2411760C/fr not_active Expired - Fee Related
- 2001-06-07 OA OA1200200372A patent/OA12286A/fr unknown
- 2001-06-07 AU AU2001266124A patent/AU2001266124A1/en not_active Abandoned
- 2001-06-07 ES ES01943580T patent/ES2248347T3/es not_active Expired - Lifetime
- 2001-06-07 EA EA200300010A patent/EA200300010A1/ru unknown
- 2001-06-07 JP JP2002501875A patent/JP4238026B2/ja not_active Expired - Fee Related
- 2001-06-07 KR KR1020027016766A patent/KR20030025931A/ko not_active Application Discontinuation
- 2001-06-07 AT AT01943580T patent/ATE305460T1/de not_active IP Right Cessation
- 2001-06-07 WO PCT/FR2001/001760 patent/WO2001094325A1/fr active IP Right Grant
-
2002
- 2002-12-02 ZA ZA200209769A patent/ZA200209769B/en unknown
- 2002-12-06 NO NO20025884A patent/NO20025884L/no not_active Application Discontinuation
- 2002-12-06 HR HR20020970A patent/HRP20020970A2/xx not_active Application Discontinuation
- 2002-12-09 EC EC2002004375A patent/ECSP024375A/es unknown
- 2002-12-09 MA MA26939A patent/MA25814A1/fr unknown
-
2004
- 2004-02-06 HK HK04100771A patent/HK1057900A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL152078A0 (en) | 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors | |
AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
AU2002226486A1 (en) | Novel c-glycoside derivatives and use thereof | |
SI1686119T1 (sl) | Derivati pirimidin-5-ona kot inhibitorji ldl-pla2 | |
AU2001244399A1 (en) | Gamma-secretase inhibitors | |
AU2001240542A1 (en) | Heterocyclic compounds and their use as parp inhibitors | |
IL153246A0 (en) | Substituted quinazoline derivatives and their use as inhibitors | |
AU2001258771A1 (en) | -secretase inhibitors | |
HK1057214A1 (en) | New mandelic acid derivatives and their use as throbin inhibitors | |
AU2002226487A1 (en) | Novel c-glycoside derivatives and use thereof | |
HUP0203961A3 (en) | 3-phenoxy-1-phenyl acetylene derivatives and their use as herbicedes | |
AU2002230836A1 (en) | Benzylamine derivatives and their use as thrombin inhibitors | |
AU2001281799A1 (en) | Benzamide derivatives and their use as apob-100 and mtp inhibitors | |
AU2001244596A1 (en) | Indolylpyrrole derivatives and cell death inhibitors | |
AU2001276027A1 (en) | Heteroaryl-beta-alanine derivatives as alpha 4 integrin inhibitors | |
AU5693101A (en) | New thiochromane derivatives and their use as thrombin inhibitors | |
AU2002216650A1 (en) | Triazine derivatives as lpaat-b inhibitors and uses thereof | |
AU4501199A (en) | 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors | |
AU2001266124A1 (en) | 2-aminothiazoline derivatives and their use as no-synthase inhibitors | |
AU2001277561A1 (en) | Biphenyl derivatives and the use thereof as integrin inhibitors | |
AU1039801A (en) | Compounds and their use as cysteine protease inhibitors | |
AU4432001A (en) | Trityl-type compounds and their use | |
AU2001259626A1 (en) | Indole derivatives and their use as 15-lipoxygenase inhibitors | |
AU2001235364A1 (en) | Tetrahydronaphtalene derivatives and their use | |
AU2001282268A1 (en) | Phenantridine derivatives and their use as anti-telomerase agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |